The Omixon web portal provides easy-to-use, cost-effective, reliable and secure software and infrastructure for calculations related to gene and genomic sequencing. The project is currently in beta but is in the manufacturing, distribution and sales phase.

Investment capital will be used for:
1) Product development and R&D: €2,000,000 (grant-funded)
2) FPGA computational infrastructure:  €500,000-€1,000,000
3) Sales, marketing and business development: €500,000-€1,000,000
4) Product enhancement: up to €1,000,000
5) The project currently has investment capital of over €2,000,000, mostly in the form of government grants

We believe this project represents an exceptional opportunity. The project owner expects a return on the total investment of €3,000,000 to €5,000,000 within 3-7 years (25-70% IRR). The exit value of the company in 5 years is forecast at €50,000,000 to €200,000,000, which would require follow-on investment rounds totalling €10,000,000 to €20,000,000. The project owner is looking for a joint-venture partner to acquire partial ownership in the company, or an investor looking to boost project capital.